4 Top-Performing Healthcare Dividend Stocks with Single-Digit P/Es

Author's Avatar
Jul 02, 2013
We’ve completed the month June and it’s time to report which stocks have risen most within the first six months of the year. It’s always good to see which stocks are hot in the market and which of them are still cheaply valuated.

That’s the main reason I like to produce an article serial with performance figures of the best performing stocks from several sectors of the financial market.

Today I would like to screen the health care sector by dividend stocks with the highest stock performance since the beginning of the year.

The 20 most successful companies have realized a performance between 22.01 percent and 73.98 percent. The average capital gain was 36.24 percent. Despite the strong stock price hike, 17 of them still have a buy or better rating.

Here are the cheapest stocks in terms of forward P/E:

Warner Chilcott (WCRX) has a market capitalization of $4.94 billion. The company employs 2,100 people, generates revenue of $2.541 billion and has a net income of $403.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1.424 billion. The EBITDA margin is 56.04 percent (the operating margin is 19.48 percent and the net profit margin 15.86 percent).

Financial Analysis: The total debt represents 94.24 percent. Twelve trailing months earnings per share reached a value of $1.60. Last fiscal year, the company paid no dividends to shareholders. Forward P/E: 6.18.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.30, the P/S ratio is 1.95 and the P/B ratio is finally not calculable. The dividend yield amounts to 2.54 percent and the beta ratio has a value of 1.09.

Questcor Pharmaceuticals (QCOR) has a market capitalization of $2.74 billion. The company employs 557 people, generates revenue of $509.29 million and has a net income of $197.68 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $299.03 million. The EBITDA margin is 58.72 percent (the operating margin is 58.22 percent and the net profit margin 38.81 percent).

Financial Analysis: The total debt represents 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 103.59 percent was realized. Twelve trailing months earnings per share reached a value of $3.23. Last fiscal year, the company paid $0.40 in the form of dividends to shareholders. Forward P/E: 9.65.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.26, the P/S ratio is 5.39 and the P/B ratio is finally 16.67. The dividend yield amounts to 2.17 percent and the beta ratio has a value of 0.67.

WellPoint (WLP) has a market capitalization of $24.52 billion. The company employs 43,500 people, generates revenue of $61.711 billion and has a net income of $2.655 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $5.118 billion. The EBITDA margin is 8.29 percent (the operating margin is 6.26 percent and the net profit margin 4.30 percent).

Financial Analysis: The total debt represents 25.41 percent of the company’s assets and the total debt in relation to the equity amounts to 62.93 percent. Due to the financial situation, a return on equity of 11.28 percent was realized. Twelve trailing months earnings per share reached a value of $8.49. Last fiscal year, the company paid $1.15 in the form of dividends to shareholders. Forward P/E: 9.87.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 9.61, the P/S ratio is 0.40 and the P/B ratio is finally 1.05. The dividend yield amounts to 1.84 percent and the beta ratio has a value of 0.86.

Humana (HUM) has a market capitalization of $13.42 billion. The company employs 43,400 people, generates revenue of $39.126 billion and has a net income of $1.222 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2.354 billion. The EBITDA margin is 6.02 percent (the operating margin is 5.15 percent and the net profit margin 3.12 percent).

Financial Analysis: The total debt represents 14.69 percent of the company’s assets and the total debt in relation to the equity amounts to 33.18 percent. Due to the financial situation, a return on equity of 14.45 percent was realized. Twelve trailing months earnings per share reached a value of $8.93. Last fiscal year, the company paid $1.03 in the form of dividends to shareholders. Forward P/E: 9.97.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 9.54, the P/S ratio is 0.34 and the P/B ratio is finally 1.52. The dividend yield amounts to 1.27 percent and the beta ratio has a value of 1.04.

Take a closer look at the full list of the best performing healthcare dividend stocks with cheap price ratios. The average P/E ratio amounts to 26.33 and forward P/E ratio is 16.64. The dividend yield has a value of 4.07 percent. Price to book ratio is 2.98 and price to sales ratio 3.77. The operating margin amounts to 27.08 percent and the beta ratio is 0.40. Stocks from the list have an average debt to equity ratio of 1.26.

Related stock ticker symbols:

QCOR, WCRX, UTMD, UHS, BMY, AET, CI, TMO, WLP, ENSG, WST, COO, STJ, BDX, MDT, STE, JNJ, HUM, ALC, UNH

Selected Articles:

· 13 Highly Shorted Healthcare Dividend Stocks

· 20 Cheapest Healthcare Dividend Stocks

· 20 Best Yielding Healthcare Stocks Less Volatile Than The Market

· 20 Of The Best Yielding Healthcare Growth Stocks For The Next Years

*If you would like to receive more dividend stock ideas and the free Dividend Weekly, you should subscribe to my free e-mail list. Alternatively, you can follow me onFacebookor Twitter.

Healthcare dividend stocks with the highest year-to-date performance originally published at long-term-investments.blogspot.com.